scispace - formally typeset
A

Ann M. Graybiel

Researcher at McGovern Institute for Brain Research

Publications -  360
Citations -  53036

Ann M. Graybiel is an academic researcher from McGovern Institute for Brain Research. The author has contributed to research in topics: Striatum & Basal ganglia. The author has an hindex of 121, co-authored 350 publications receiving 49771 citations. Previous affiliations of Ann M. Graybiel include Case Western Reserve University & Tufts University.

Papers
More filters
Journal ArticleDOI

Patterns of muscarinic cholinergic binding in the striatum and their relation to dopamine islands and striosomes.

TL;DR: The distribution of muscarinic cholinergic binding sites in the striatum was studied in relation to the locations of other neurochemical markers in the developing rat, cat, ferret, and human.
Journal ArticleDOI

A stereometric pattern of distribution of acetylthiocholinesterase in the deep layers of the superior colliculus

TL;DR: Evidence is presented here that enzyme-positive clumps in the deep collicular layers of the superior colliculus are also seen in the monkey and that, in the cat at least, these clumps do indeed form longitudinal bands.
Journal ArticleDOI

Patterns of cell and fiber vulnerability in the mesostriatal system of the mutant mouse weaver. I. Gradients and compartments

TL;DR: The effects of the weaver gene discriminate among mesostriatal subsystems not only according to the regional affiliations of these subsystems within the dorsal and ventral striatum, but also according toThe preferential association of the subsystems for the striosomal and matrical compartments of the caudoputamen.
Journal ArticleDOI

Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartments.

TL;DR: It is reported here that desipramine-sensitive [3H]mazindol binding sites have highly heterogeneous distributions in the dorsal and the ventral striatum, and the possibility that these distributions could result in selective neuronal vulnerability to neurotoxins, such as 1-methyl-4-phenylpyridine (MPP+), that depend on the dopamine-uptake complex for entry into neurons.